Related Experiment Video

Updated: Aug 2, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Could peripartum antibiotics have delayed health consequences for the infant?

A R Bedford Russell1, S H Murch

  • 1Heart of England NHS Trust, Birmingham, UK.

BJOG : an International Journal of Obstetrics and Gynaecology
|July 11, 2006
PubMed

Insights

Perinatal antibiotic use can alter infant gut microbes, potentially leading to long-term health issues. Research highlights the need to study these effects on immune and metabolic development in children.

Area of Science:

  • Microbiology
  • Neonatal Health
  • Immunology

Background:

  • Antibiotics are frequently used during the peripartum period for maternal and fetal health.
  • While reducing some neonatal infections like group B streptococcal disease, broad-spectrum antibiotics may shift infections to less common organisms.
  • Long-term outcomes of perinatal antibiotic exposure on infant health remain understudied.

Purpose of the Study:

  • To review the impact of perinatal antibiotic regimens on gut flora composition.
  • To summarize recent scientific findings on the importance of gut flora for immune tolerance and metabolism.
  • To highlight the need for long-term outcome studies in children exposed to perinatal antibiotics.

Main Methods:

  • Literature review of published data on perinatal antibiotic exposure and infant gut microbiota.
  • Synthesis of recent scientific findings on the role of gut flora in host immune and metabolic programming.
  • Analysis of studies examining long-term health outcomes in children.

Main Results:

  • Early-life gut colonization by specific organisms can lead to chronic persistence.
  • Gut microbiota composition influences host immune function and metabolic programming.
  • Perinatal antibiotic use alters the infant gut microbiome, with potential long-term consequences.

Conclusions:

  • Perinatal antibiotic exposure significantly impacts the developing infant gut microbiome.
  • Altered gut flora may have long-term implications for immune and metabolic health in children.
  • Further research is crucial to understand and mitigate the long-term effects of perinatal antibiotics.

More Related Videos

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...